Miller, Ann M.
Lemke-Miltner, Caitlin D.
Blackwell, Sue
Tomanek-Chalkley, Ann
Gibson-Corely, Katherine N.
Coleman, Kristen L.
Weiner, George J.
Chan, Carlos H. F.
Funding for this research was provided by:
National Institutes of Health (T32 CA078586)
National Cancer Institute (P30 CA086862)
Holden Comprehensive Cancer Center, University of Iowa (Mezhir Awards for Collaborative Research)
Article History
Received: 4 March 2020
First Online: 14 May 2020
Disclosure
: Caitlin Lemke-Miltner holds stock options in Checkmate Pharmaceuticals. Sue Blackwell owns stocks and holds stock options in Checkmate Pharmaceuticals. George J. Weiner received research funding from Checkmate Pharmaceuticals, but not for this work. Carlos H. F. Chan received the study compound CMP-001 from Checkmate Pharmaceuticals, but did not receive any research funding for this work.